Medicine & TechnologyProfessor Sarah Gilbert, who leads Oxford University's trial for its coronavirus vaccine candidate, says their jab could provide long-term immunity, which could last for several years. Furthermore, she says it could even give off antibodies three times more than a person who recovered from COVID-19.
Oxford's experimental coronavirus vaccine, ChAdOx1 vaccine, passed its clinical trial on monkeys with flying colors. With the company just merely getting started on human trials, the Serum Institute of India, the world's largest vaccine manufacturer, vouched to start making doses of the vaccine ASAP, in case it worked. Click the link to read the full story.